The U.S. Department of Defense Awards CytoSorbents an Approx

The U.S. Department of Defense Awards CytoSorbents an Approximately $2.0M Contract to Support HemoDefend-BGA™ Development for Life-saving Universal Plasma

PRINCETON, N.J., Sept. 9, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions i...

Related Keywords

United States , Russia , Ukraine , Maryann Gruda , Eric Kim , Amy Vogel , Cytosorbent Hemodefend , Vincent Capponi , Twitter , Department Of Defense , Material Command , Us Department Of Defense Do , Ready Blood Group Antibody , Us Army Medical Research Acquisition Activity , Development Program , Casualty Care Research Program , European Union , Us Army , Defense Medical Research , Blood Institute , Cytosorbents Corporation , National Heart , Us Department Of Health , Human Services , Casualty Care Research , National Institutes Of Health , Research Programs , World Health Organization , Us Air , Program Committee , Dod Defense Health Program , Health Affairs , Sorbents Corporation , Medical Research Acquisition Activity , Combat Casualty Care Research Program , Combat Casualty Care Research Program Funded , Peer Reviewed Medical Research Program , Congressionally Directed Medical Research , Principal Investigator , Senior Director , Chief Operating Officer , Fort Detrick , Assistant Secretary , Joint Program Committee , Battlefield Resuscitation , Immediate Stabilization , Combat Casualties , Field Ready Blood Group Antibody , Porcine Universal Transfusion Model , American Red Cross , About Cytosorbents Corporation , Use Authorization , Device Designations , Timely Antithrombotic Removal Ticagrelor , National Institutes , Operations Command , Air Force Material Command , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Relations Contact , Rubenstein Public ,

© 2025 Vimarsana